MedTrace Logo

12-Week Efficacy Clinical Study of Serum

NCT06968416 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2025-05-13

No results posted yet for this study

Summary

65 female adult subjects will be enrolled in the study, recruited according to inclusion and non-inclusion criteria listed above. At least 40 subjects should complete the clinical evaluation and 60 subjects should complete consumer questionnaire in this 15-week study (wash-out phase for 3 weeks and treatment phase for 12 weeks). Subjects will need to refrain from using any product other than the provided test products on whole face including eye area during the 3-week wash-out phase and 12-week study treatment phase.

Conditions

  • Anti-aging
  • Female

Interventions

OTHER

Standard cleanser，standard moisturizer，standard sunscreen，Investigational serum

Products Application and Usage Instruction 1. Mode of application: T-3W \~ T0 Frequency: AM: Standard cleanser + standard moisturizer + standard sunscreen PM: Standard cleanser + standard moisturizer Caution: No any other skincare or facial make up products are used except provide products 2. Mode of application: T0 \~ T12W Frequency: AM: Standard cleanser + Investigational serum (face and eye) \[FLA #774715 21\] + standard moisturizer + standard sunscreen PM: Standard cleanser + Investigational serum (face and eye) \[FLA #774715 21\] + standard moisturizer Caution: No any other skincare or facial make up products are used except provide products Usage Instruction： Use serum \[FLA #774715 21\] 8-10 drops (0.3ml) on cleansed face and eye skin 2 times a day (AM \& PM).

Sponsors & Collaborators

  • ChinaNorm

    lead INDUSTRY

Principal Investigators

  • Ping Xu, Master · Shanghai China-norm Quality Technical Service Co., Ltd.

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-02
Primary Completion
2023-11-17
Completion
2023-11-17

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06968416 on ClinicalTrials.gov